Cita APA

Zheng, Q., Tang, J., Aicher, A., Bou Kheir, T., Sabanovic, B., Ananthanarayanan, P., . . . Heeschen, C. (2023). Inhibiting NR5A2 targets stemness in pancreatic cancer by disrupting SOX2/MYC signaling and restoring chemosensitivity.

Citación estilo Chicago

Zheng, Quan, et al. Inhibiting NR5A2 Targets Stemness in Pancreatic Cancer By Disrupting SOX2/MYC Signaling and Restoring Chemosensitivity. 2023.

Cita MLA

Zheng, Quan, et al. Inhibiting NR5A2 Targets Stemness in Pancreatic Cancer By Disrupting SOX2/MYC Signaling and Restoring Chemosensitivity. 2023.